We all know that prevention in medicine is the best way to help people at risk. The medical community embraces prevention in oncology, CNS, and diabetes. However, we must improve the preventive actions taken in approaching cardiovascular diseases (CVD), as these remain the leading cause of death in the western world. There is an ongoing debate regarding the use of aspirin, one of the oldest drugs used, discovered in 1899, for the prevention of CVD. The varying considerations around the use of aspirin include how to use it, when to use it, and who are the ideal patients to receive it.
In addition to the linked article, the last in a long series of position papers commenting on the use of aspirin in the prevention of CVD, we have also solicited the input of a cardiologist who serves on the Academy’s Board. Look for part 2 in this series about prevention for his comments. In the meantime, read the position paper here.
Disclaimers
- The material in these reviews is from various public open access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
